Cancer HealthCast: NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
Proteomics is an emerging field in cancer care and research. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) aims to get to the heart of cancer by studying its molecular basis across different cancers. The group believes expanding open-source resources and other data can lead to new treatments in cancer and expand precision medicine.
Dr. Henry Rodriguez, the founding director of the Office of Cancer Clinical Proteomics Research at NCI, discusses the program and how the related International Cancer Proteogenome Consortium (ICPC) is helping researchers pull together resources necessary to innovate cancer care.
-
Dr. Henry Rodriguez Founding Director, Office of Cancer Clinical Proteomics Research NCI
-
VA Site Redesign Simplifies Veterans' Access to Services
New features on VA.gov include improved sign-on options and AI-powered search to benefits and services, officials said.
3m read -
GAO's Take on AI Costs, Cyber Risks in Federal Tech Strategies
Rising costs require government agencies to navigate how to consider AI use, evolving policies and the workforce in the loop.
4m read -
VBA Seeks Faster Claims With Day-One Access to Military Records
A partnership with the War Department gives the agency earlier access to records and reduces administrative delays around claims.
2m read -
When Tackling AI Risk, Feds Say It’s All About Data, Governance
Government AI leaders discussed how data governance, trust and risk management are shaping adoption of agentic AI across agencies.
3m read
